Key facts
- Ascenta Capital is a venture capital firm based in New York, New York with 8 tracked portfolio companies.
- Notable positions include Tubulis, Cardurion, Iambic, Odyssey Therapeutics, OrsoBio.
- Ascenta Capital has 1 fund on record, raising $325 across the 1 that report a size.
- The team roster lists 10 people.
About Ascenta Capital
Founded in 2023, Ascenta Capital is a venture capital firm based in New York. The firm seeks to invest in the biotechnology sector.
Free account
See the whole book
- ·Watchlist + alerts for Ascenta Capital's activity
Create free account
No card required
Portfolio, priced
8 companies · by our current valuations| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| Tubulis | Drug Discovery | $5.8B | — | |
| Cardurion | Biotechnology | $760.0M | — | |
| Iambic | — | $648.0M | — | |
| Odyssey Therapeutics | Biotechnology | $638.2M | — | |
| OrsoBio | — | $310.0M | — | |
| TRIANA Biomedicines | Discovery Tools (Healthcare) | $258.0M | — | |
| Angitia Biopharmaceuticals | Drug Discovery | — | — | |
| Alpha-9 Oncology | Biotechnology | — | — |
Funds
1 recorded- Ascenta Capital Fund I2023$325
$325 raised across the 1 fund that report a size
Team
10 people on record — 9 with verified contacts
Partners, principals, and the people who answer a pitch. Pro members reveal contacts with credits.
Frequently asked
- What companies does Ascenta Capital invest in?
- Ascenta Capital has 8 recorded portfolio companies, including Tubulis, Cardurion, Iambic, Odyssey Therapeutics.